• Skip to main content
  • Skip to primary sidebar

dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for early-life nutrition 

Asia Food Journal
Leaderboard of Asia Food Journal
  • Home
  • Latest News
  • Channels
    • Packaging
    • Processing
    • Ingredients
    • Industry
    • Automation
    • Guest Posts
    • Market Trends
  • Subscribe
  • Advertise
  • Event Calendar
  • Contact Us
    • Submit Guest Posts
Share




dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for early-life nutrition 

October 11, 2023 by Asia Food Journal

HMO Ingredients

Courtesy of Hans Reniers/Unsplash

dsm-firmenich, the leading innovator in health, nutrition, and beauty, announced that two of its human milk oligosaccharide (HMO) ingredients had been approved as fortifiers for infant nutrition in China. This approval is a significant milestone as it will create new opportunities for innovation in the field of early-life nutrition and make the unique benefits of HMOs accessible to infants and young children in China.  

The only two approved HMO ingredients in the Chinese market 

The two HMOs that received approval in China include GlyCare™ 2’-fucosyllactose (2’-FL), the most prevalent HMO in human breast milk, and GlyCare™ lacto-N-neotetraose (LNnT), a complex sugar in human milk that is biologically relevant in the early development of the infant gut flora. The 2’-FL HMO has been approved for use in four food categories, including infant formula, formula for elder infants and young children, infant formula for special medical purposes, and formulated milk powder at a usage level between 0.7-2.4 g/L. LNnT is available for the same applications at 0.2-0.6 g/L.  

Leaderboard of Asia Food Journal

Data on concentrations of HMOs found in human breast milk globally were taken into consideration by the China National Center for Food Safety Risk Assessment (CFSA) to set the approved maximum usage level. Currently, 2’-FL and LNnT are the only HMO ingredients approved in the Chinese market. 

“We are extremely pleased to be able to announce this huge milestone for the China infant formula market and dsm-firmenich,” says James Young, Vice-President of Early Life Nutrition at dsm-firmenich. “As the only company with these two HMOs approved for use in China, this approval reaffirms dsm-firmenich’s lead position in the global HMO market. HMOs are the next important ingredient for bringing the composition of infant formula closer to breast milk, the gold standard of infant nutrition, and this approval ensures that all infants in China now have access to this important nutrient.” 

Christoph Röhrig, Head of HNC Glycans & HMO Regulatory Affairs at dsm-firmenich added: “We followed a rigorous regulatory process to ensure all safety and health requirements were met. In the first phase of this process, we achieved safety clearance from the Chinese Ministry of Agriculture and Rural Affairs (MARA) for several of our HMO production strains, including 2’-FL and LNnT. This was followed by the food additive approval process, which comprised a rigorous multiple phase technical assessment by the China National Center for Food Safety Risk Assessment (CFSA), including the opportunity for public comments that required the questions of diverse stakeholders to be addressed. With this breakthrough approval of two of our leading HMO ingredients in China, we are now able to offer two very important HMOs to the domestic infant nutrition market.” 

HMOs are a powerful emerging ingredient capturing increasing attention across the health and nutrition space due to recent technological advancements and a growing bank of scientific evidence showing their potential benefits, modes of action, and applications. An important component of human breast milk, HMOs have demonstrated to play a fundamental role in infant health by supporting immune function, gut health, and potentially cognitive development.i, ii, iii, iv 

As a leader in HMO research, development, and production, dsm-firmenich is continuously pioneering advancements in this field and expanding its offering across the early-life nutrition and dietary supplement markets.  

The company’s science-backed GlyCare™ HMO portfolio is already available for use in more than 160 countries worldwide.   

About dsm-firmenich 

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. 

www.dsm-firmenich.com 

[i] Sprenger N, Tytgat HLP, Binia A, Austin S, Singhal A. Biology of human milk oligosaccharides: From basic science to clinical evidence. J Hum Nutr Diet. 2022 Apr;35(2):280-299. doi: 10.1111/jhn.12990.

[ii] Puccio G, Alliet P, Cajozzo C, Janssens E, Corsello G, Sprenger N et al. (2017). Effects of infant formula with human milk oligosaccharides on growth and morbidity: a randomized multicenter trial. J Pediatr Gastroenterol Nutr 64(4):624-631. DOI:10.1097/MPG.0000000000001520.

[iii] Berger B, Porta N, Foata F, Grathwohl D, Delley M, Moine D, et al. (2020). Linking human milk oligosaccharides, infant fecal community types, and later risk to require antibiotics. mBio 11(2):e03196-19 [18pp]. DOI:10.1128/mBio.03196-19.

[iv] Vandenplas Y, Żołnowska M, Berni Canani R, Ludman S, Tengelyi Z, Moreno-Álvarez A, et al. (2022). Effects of an extensively hydrolyzed formula supplemented with two human milk oligosaccharides on growth, tolerability, safety and infection risk in infants with cow’s milk protein allergy: a randomized, multi-center trial (CINNAMON Study Investigator Group). Nutrients 14(3):530 [14pp]. DOI:10.3390/nu14030530.

Other Topics: dsm-firmenich, Early-life nutrition, healthy ingredients, HMO ingredients, Ingredients

Related Articles

  • MAFI for Agricultural Produce Industries Logo

    Courtesy of MAFI for Agricultural Produce Industries

    MAFI to showcase premium B2B agri-food ingredients at PLME 2025 
  • A comparison of Metaberine and Berberine powders

    Courtesy of Zeus Hygia

    Zeus Hygia unveils Metaberine: The world’s first green process, enriched berberine powered by proprietary technology
  • living income in the Food Agri and Food Retail sectors

    Courtesy of ofi

    ofi recognised as the most advanced company on living income in the Food Agri and Food Retail sectors  
  • asparagopsis seaweed

    Courtesy of CH4 Global

    ‘Better Beef’ on Adelaide shelves in world first 
  • bottles of avocado oils

    Courtesy of Westfalia Fruit

    Westfalia Fruit wins gold and silver for avocado oils at inaugural SA Food & Beverage Awards 2025
  • plant-based EXBERRY® colors

    Courtesy of GNT Group

    GNT to showcase plant-based EXBERRY® colors as alternatives to synthetic dyes at Fi Asia 2025




Primary Sidebar

Stay Connected

Your browser does not support the video tag. Learn More

Trending News

  • limited edition Pocky durian and Pocky ondeh-ondeh flavoursPocky launches limited edition Pocky durian and… This National Day season, Glico is marking Singapore’s 60th birthday…
  • soft drinks marketSingapore soft drinks market hits SGD12B as health… Singapore’s soft drinks market has reached a value of SGD…
  • Starbucks TaiwanStarbucks Taiwan unveils its largest flagship store… A one-of-a-kind destination blending coffee exploration, culinary innovation, and sustainable…
  • asparagopsis seaweed‘Better Beef’ on Adelaide shelves in world first  A milestone is being celebrated in the emissions reductions race,…
  • Fi Asia Thailand 2025Fi Asia Thailand 2025 registration opens:… Organisers expect a record-breaking showcase of ingredient innovations from 17-19…
  • Kerry Jakarta officeKerry expands innovation footprint in Southeast Asia… Kerry, a global leader in taste and nutrition, officially opened…
  • AgridenceAgridence transitions to founder-led governance,… Additional funding allows Agridence to better deliver its traceability modules…

Subsribe to Our News Letter

Subscribe To
Our Newsletter


By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

© 2025 Harvest Information. All rights reserved. Privacy Policy.

Disclaimer: Translations on this website are automated using Google Translate. While we strive for accuracy, please be cautious, as machine translations may contain errors. For critical or sensitive content, consider seeking professional human translation. We are not liable for any reliance on the translated content.

Become an F&B industry insider

Your go-to resource for all the latest trends, innovations, and news about the food and beverage industry!

 

By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.